Essex Financial Services’s CorMedix CRMD Stock Holding History

Essex Financial Services’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$80.9K	Buy	11,919 +1,208	+11%	+$8.93K	﹤0.01%	785
2025 Q4	$125K	Buy	10,711 +300	+3%	+$3.32K	0.01%	770
2025 Q3	$121K	Buy	+10,411	New	+$126K	0.01%	740
2025 Q2	–	Sell	-10,263	Closed	-$63.2K	–	692
2025 Q1	$63.2K	Buy	+10,263	New	+$106K	﹤0.01%	626
2019 Q4	–	Sell	-10,000	Closed	-$64K	–	273
2019 Q3	$64K	Buy	+10,000	New	+$84K	0.02%	247
2019 Q2	–	Sell	-10,000	Closed	-$95K	–	246
2019 Q1	$95K	Buy	+10,000	New	+$90.1K	0.03%	233

Other funds holding CRMD

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Essex Financial Services's CRMD Position: Q1 2026 in Review

Essex Financial Services increased its CorMedix (CRMD) stake by 11% in Q1 2026, buying an estimated $8.93K and bringing the position to 11,919 shares worth $80.9K. The position accounts for ﹤0.01% of the portfolio, ranked #785.

Essex Financial Services first reported a position in CRMD in Q1 2019 and has held it in 6 quarters since. The position peaked at $125K in Q4 2025. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

Essex Financial Services held 11,919 shares of CorMedix worth $80.9K as of Q1 2026.
Essex Financial Services bought 1,208 CorMedix shares in Q1 2026, an estimated $8.93K.
CorMedix made up ﹤0.01% of Essex Financial Services's portfolio in Q1 2026, its #785 holding.
Essex Financial Services first reported a position in CorMedix in Q1 2019 and has held it in 6 quarters since.
Essex Financial Services's CorMedix position peaked at $125K in Q4 2025.
187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Essex Financial Services's 13F filing for Q1 2026, filed 24 Apr 2026.